CHANTIBODY
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Jun 2025)
What this means for you
This application is over — abandoned 16 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98128436
- Mark type
- Design + words
- Filed
- 11 Aug 2023
- Published for opposition
- 17 Sept 2024
- Abandoned
- 16 Jun 2025
- Attorney of record
- Milica Bosnjak
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer, immunological-inflammatory and other chronic conditions; Biological products, namely, a drug delivery system comprising antibodies or antibody fragments which extend the effect of a wide variety of therapeutic agents, for medical use and for use in medical treatment; Diagnostic preparations for medical purposes; Vaccines for human use; Therapeutic vaccines; Medical preparations, namely, antibodies and antibody fragments, for treatment of inflammatory diseases, neoplastic diseases, autoimmune diseases, and cancer; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Pharmaceutical preparations for the treatment and/or prophylaxis of chronic disease
Owner
- Chantibody Therapeutics Inc., California, CA, US
- Chantibody Therapeutics Inc., California, CA, US
Prosecution history
- 16 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jun 2024 — NON-FINAL ACTION E-MAILED
- 05 Jun 2024 — NON-FINAL ACTION WRITTEN
- 09 Apr 2024 — ASSIGNED TO EXAMINER
- 12 Sept 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED